ClinicalTrials.gg
Enrolling by invitationNCT07578181Updated May 11, 2026

Aromatherapy Massage in Chronic Low Back Pain

An interventional study of Conventional Physiotherapy and Aromatherapy Massage + Conventional Physiotherapy in Low Back Pain, sponsored by Kirsehir Ahi Evran Universitesi. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by Kirsehir Ahi Evran Universitesi · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as enrolling by invitation.
  • Registered 11 months after the study started (first participant enrolled May 2025, registered May 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi — 5 open to participants now, 5 under way, none of them phase 3. Low Back Pain · Kirsehir Ahi Evran Universitesi.

Started
2025
with 3 others
No phase
9 of 13
3 open now
Registered
12th of 13
by date

Among the 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi, this one is one of 4 that started in 2025, is one of 9 with no phase, and was the 12th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

5 of the 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi, or all of them as a file.
02

Study summary

The aim was to investigate the effectiveness of adding aromatherapy massage with a mixture of lavender and orange oil to conventional physical therapy in individuals with chronic nonspecific low back pain on pain, central sensitization, functionality, sleep, quality of life, kinesiophobia, anxiety, and depression in this patient population.

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Low Back Pain
  • Aromatherapy
  • Massage
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-65 years
  • Chronic nonspecific low back pain ≥ 6 months
  • Volunteering to participate
  • Receiving treatment at physical therapy clinic

Exclusion criteria

Exclusion Criteria

  • History of orthopedic surgery, fracture, trauma
  • Inflammatory, rheumatologic, neurological, psychiatric disorders
  • Asthma
  • Current psychiatric medication use
  • Peripheral neuropathy or postherpetic neuralgia
  • Long-term use
  • Skin lesions/open wounds in treatment area
  • Allergy to lavender, orange, or almond oil
  • Positive allergic reaction to patch test
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Active comparator
    Conventional Physiotherapy

    Hotpack (10 min) TENS (20 min) Ultrasound (5 min) Stretching \& stabilization exercises (15 min) Frequency: 5 sessions/week for 4 weeks

    Other: Conventional Physiotherapy

  • Experimental
    Aromatherapy Massage + Conventional Physiotherapy

    Same conventional physiotherapy protocol Aromatherapy massage: Lavender + orange essential oil (%1.5 in sweet almond oil) 15 min/session 3 sessions/week for 4 weeks Massage techniques: effleurage, petrissage, friction, vibration

    Other: Aromatherapy Massage + Conventional Physiotherapy

Interventions

  • OtherConventional Physiotherapy

    Hotpack (10 min) TENS (20 min) Ultrasound (5 min) Stretching \& stabilization exercises (15 min) Frequency: 5 sessions/week for 4 weeks

  • OtherAromatherapy Massage + Conventional Physiotherapy

    Same conventional physiotherapy protocol Aromatherapy massage: Lavender + orange essential oil (%1.5 in sweet almond oil) 15 min/session 3 sessions/week for 4 weeks Massage techniques: effleurage, petrissage, friction, vibration

06

What researchers measure

Primary outcomes

  1. McGill Pain Questionnaire

    The McGill Pain Questionnaire Short Form consists of 15 items evaluating sensory and affective dimensions of pain. Each item is scored on a 0-3 Likert scale, with total scores ranging from 0 to 45. Higher scores indicate greater pain severity.

    Time frame: Baseline, 4 weeks

  2. Pressure Pain Threshold (Algometer)

    Pressure pain threshold will be measured using an algometer to evaluate sensitivity in predefined anatomical points. The device quantifies the minimum pressure that induces pain.

    Time frame: Baseline, 4 weeks

  3. Central Sensitization Inventory

    The Central Sensitization Inventory is a 25-item questionnaire assessing symptoms related to central sensitization. Each item is scored on a 5-point Likert scale (0-4), with total scores ranging from 0 to 100. Higher scores indicate greater central sensitization symptoms.

    Time frame: Baseline and 4 weeks

Secondary outcomes

  1. Disability (Oswestry Disability Index)

    The Oswestry Disability Index consists of 10 items assessing functional disability related to low back pain. Each item is scored from 0 to 5, with total scores converted into percentage disability (0-100%).

    Time frame: Baseline and 4 weeks

  2. Quality of Life (SF-36)

    The SF-36 Health Survey evaluates quality of life across 8 domains including physical functioning, role limitations, pain, general health, vitality, social functioning, emotional role, and mental health. Scores range from 0 to 100, with higher scores indicating better health status.

    Time frame: Baseline and 4 weeks

  3. Anxiety (Beck Anxiety Inventory)

    The Beck Anxiety Inventory is a 21-item scale measuring anxiety severity. Each item is scored from 0 to 3, with total scores ranging from 0 to 63.

    Time frame: Baseline and 4 weeks

  4. Depression (Beck Depression Inventory)

    The Beck Depression Inventory consists of 21 items assessing depressive symptoms. Total scores classify depression severity as minimal, mild, moderate, or severe.

    Time frame: Baseline and 4 weeks

  5. Kinesiophobia (Tampa Scale of Kinesiophobia)

    The Tampa Scale of Kinesiophobia includes 17 items rated on a 4-point Likert scale. Total scores range from 17 to 68, with higher scores indicating greater fear of movement.

    Time frame: Baseline and 4 weeks

  6. Sleep Quality (Pittsburgh Sleep Quality Index)

    The Pittsburgh Sleep Quality Index evaluates sleep quality across 7 components. Total scores range from 0 to 21, with scores above 5 indicating poor sleep quality.

    Time frame: Baseline and 4 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Jun 2026, 13 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 13 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2026
First posted
May 11, 2026
StartActual
May 20, 2025
Primary completionEst.
Jun 20, 2026
CompletionEst.
Aug 20, 2026
Last update
May 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07578181
Responsible party
Atahan TURHAN (Dr. Lecturer, Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
May 11, 2026
Start date
May 20, 2025
Primary completion
Jun 20, 2026 (estimated)
Completion
Aug 20, 2026 (estimated)
Last update
May 11, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion